Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset.
Ajeganova S, Andersson ML, Hafström I; BARFOT Study Group. Ajeganova S, et al. Arthritis Care Res (Hoboken). 2013 Jan;65(1):78-87. doi: 10.1002/acr.21710. Arthritis Care Res (Hoboken). 2013. PMID: 22514159
Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.
Tesfa D, Ajeganova S, Hägglund H, Sander B, Fadeel B, Hafström I, Palmblad J. Tesfa D, et al. Among authors: ajeganova s. Arthritis Rheum. 2011 Aug;63(8):2209-14. doi: 10.1002/art.30427. Arthritis Rheum. 2011. PMID: 21560117
The highest incidence was observed in granulomatosis with polyangiitis (Wegener's) and systemic lupus erythematosus patients (23% and 20%, respectively), whereas the incidence in rheumatoid arthritis patients was 3%. ...
The highest incidence was observed in granulomatosis with polyangiitis (Wegener's) and systemic lupus erythematosus patients (23% and …
Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study.
Ajeganova S, Ehrnfelt C, Alizadeh R, Rohani M, Jogestrand T, Hafström I, Frostegård J. Ajeganova S, et al. Rheumatology (Oxford). 2011 Oct;50(10):1785-93. doi: 10.1093/rheumatology/ker204. Epub 2011 Jul 9. Rheumatology (Oxford). 2011. PMID: 21743088
Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study.
Ajeganova S, Fiskesund R, de Faire U, Hafström I, Frostegård J. Ajeganova S, et al. Clin Exp Rheumatol. 2011 Nov-Dec;29(6):942-50. Epub 2011 Dec 22. Clin Exp Rheumatol. 2011. PMID: 22153361
Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.
Ajeganova S, de Faire U, Jogestrand T, Frostegård J, Hafström I. Ajeganova S, et al. J Rheumatol. 2012 Jun;39(6):1146-54. doi: 10.3899/jrheum.111334. Epub 2012 May 15. J Rheumatol. 2012. PMID: 22589258
Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S, Andersson ML, Frostegård J, Hafström I. Ajeganova S, et al. J Rheumatol. 2013 Dec;40(12):1958-66. doi: 10.3899/jrheum.130365. Epub 2013 Aug 15. J Rheumatol. 2013. PMID: 23950188
Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.
Ajeganova S, Svensson B, Hafström I; BARFOT Study Group. Ajeganova S, et al. BMJ Open. 2014 Apr 7;4(4):e004259. doi: 10.1136/bmjopen-2013-004259. BMJ Open. 2014. PMID: 24710131 Free PMC article. Clinical Trial.
The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis.
van Steenbergen HW, Ajeganova S, Forslind K, Svensson B, van der Helm-van Mil AH. van Steenbergen HW, et al. Among authors: ajeganova s. Ann Rheum Dis. 2015 Jan;74(1):e3. doi: 10.1136/annrheumdis-2014-206623. Epub 2014 Oct 6. Ann Rheum Dis. 2015. PMID: 25288634 No abstract available.
Rheumatoid arthritis: Seronegative and seropositive RA: alike but different?
Ajeganova S, Huizinga TW. Ajeganova S, et al. Nat Rev Rheumatol. 2015 Jan;11(1):8-9. doi: 10.1038/nrrheum.2014.194. Epub 2014 Nov 18. Nat Rev Rheumatol. 2015. PMID: 25403158 No abstract available.
Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.
Ajeganova S, Gustafsson T, Jogestrand T, Frostegård J, Hafström I. Ajeganova S, et al. Arthritis Res Ther. 2015 Mar 25;17(1):84. doi: 10.1186/s13075-015-0595-4. Arthritis Res Ther. 2015. PMID: 25885788 Free PMC article.
42 results
Jump to page
Feedback